Inventor

Nellikunja J. Prakash

Inventor

Cincinnati, OH, US

Overview

17→

Patents

1978–1998

Patent span

Human necessities

Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes41%

C07DHeterocyclic compounds28%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%

C07HSugars10%

C07CAcyclic or carbocyclic compounds7%

Y02ATechnologies for adaptation to climate change3%

PatentTitleYear

5,719,193'Method of potentiating cell-mediated immunity utilizing polyamine derivatives'1998 5,654,484'Polyamine derivatives as antineoplastic agents'1997 5,654,287'Method of treating cancer by conjunctive therapy with N,N.sup.1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent'1997 5,646,124'Method of treating cancer by conjunctive therapy with N,N\'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent'1997 5,635,218'Method of treating cancer by conjunctive therapy with N,N\'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent'1997 5,561,136'Method of treating cancer by conjunctive therapy with N,N\'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent'1996 5,521,162'Aristeromycin analogues of 4\',5\'-didehydro-5\'-fluoro-adenosine and methods of treating neoplastic and viral disease conditions'1996 5,109,024'Polyamine derivatives as antineoplastic agents'1992 4,997,924'5\'-deoxy-4\',5\'-unsaturated-5\'-substituted adenosines'1991 4,996,308'Derivatives with unsaturated substitutions for the 5\'-hydroxymethyl group'1991 4,499,072'Process for treating diseases with ODC inhibitors'1985 4,226,882'Use of .alpha.,.alpha.\'-dithiobis-(.beta.-arylacrylic acid) derivatives in the treatment of hypertension'1980 4,210,665'Use of .alpha.,.alpha.\'-dithiobis(.beta.-arylacrylic acid) derivatives in heavy metal poisoning'1980 4,210,664'Use of .alpha.,.alpha.\'-dithiobis(.beta.-arylacrylic acid) derivatives to enhance zinc serum and tissue concentrations'1980 4,169,149'Use of .alpha.-mercapto-.beta.-arylacrylic acid derivatives in heavy metal poisoning'1979 4,130,653'Method of treating hypertension'1978 4,124,718'Enhancing zinc serum and tissue levels'1978

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1978–1980Patents assigned to MERRELL TORAUDE & CO (5)· patent assignee history

1978–1980Based in Strasbourg, FR· patent location history

1979Patents assigned to GIROUX EUGENE L (1)· patent assignee history

1985–1992Patents assigned to MERRELL DOW PHARMA (4)· patent assignee history

1985–1998Based in Cincinnati, OH, US· patent location history

1996–1998Patents assigned to MERRELL PHARMA INC (6)· patent assignee history

1997Patents assigned to MERRELL PHAMACEUTICALS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MERRELL PHARMA INC	6	1996–1998
MERRELL TORAUDE & CO	5	1978–1980
MERRELL DOW PHARMA	4	1985–1992
GIROUX EUGENE L	1	1979
MERRELL PHAMACEUTICALS INC	1	1997

Locations

Location	Patents	Span
Cincinnati, OH, US	11	1985–1998
Strasbourg, FR	6	1978–1980